RYTM Historical PE Ratio image   This RYTM PE ratio history page last updated 8/4/2022
RYTM Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/2/2022
14.17-0.89-3.56NA
Q1 2022
5/3/2022
6.13-1.05-4.20NA
Q4 2021
3/1/2022
8.49-0.85-3.40NA
Q3 2021
11/2/2021
12.90-0.70-2.80NA
Q2 2021
8/3/2021
16.63-0.70-2.80NA
Q1 2021
5/3/2021
21.95-0.47-1.88NA
Q4 2020
3/1/2021
26.84-0.79-3.16NA
Q3 2020
11/2/2020
21.59-0.77-3.08NA
Q2 2020
8/3/2020
20.20-0.71-2.84NA
Q1 2020
5/4/2020
19.02-0.78-3.12NA
Q4 2019
3/2/2020
20.42-0.78-3.12NA
Q3 2019
11/1/2019
21.70-1.04-4.16NA
Q2 2019
7/29/2019
19.89-1.24-4.96NA
Q1 2019
5/3/2019
25.57-0.84-3.36NA
Q4 2018
3/8/2019
27.92-0.74-2.96NA
Q3 2018
11/9/2018
29.35-0.52-2.08NA
Q2 2018
8/8/2018
31.83-0.52-2.08NA
Q1 2018
5/14/2018
28.58-0.60-2.40NA
Q4 2017
3/12/2018
27.34-0.41-1.64NA
Q3 2017
11/14/2017
24.02-1.78-7.12NA
RYTM PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/2/2022
14.17-0.89-3.49NA
Q1 2022
5/3/2022
6.13-1.05-3.30NA
Q4 2021
3/1/2022
8.49-0.85-2.72NA
Q3 2021
11/2/2021
12.90-0.70-2.66NA
Q2 2021
8/3/2021
16.63-0.70-2.73NA
Q1 2021
5/3/2021
21.95-0.47-2.74NA
Q4 2020
3/1/2021
26.84-0.79-3.05NA
Q3 2020
11/2/2020
21.59-0.77-3.04NA
Q2 2020
8/3/2020
20.20-0.71-3.31NA
Q1 2020
5/4/2020
19.02-0.78-3.84NA
Q4 2019
3/2/2020
20.42-0.78-3.90NA
Q3 2019
11/1/2019
21.70-1.04-3.86NA
Q2 2019
7/29/2019
19.89-1.24-3.34NA
Q1 2019
5/3/2019
25.57-0.84-2.62NA
Q4 2018
3/8/2019
27.92-0.74-2.38NA
Q3 2018
11/9/2018
29.35-0.52-2.05NA
Q2 2018
8/8/2018
31.83-0.52-3.31NA
Q1 2018
5/14/2018
28.58-0.60NANA
Q4 2017
3/12/2018
27.34-0.41NANA
Q3 2017
11/14/2017
24.02-1.78NANA
Quotes delayed 20 minutes

Email EnvelopeFree RYTM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Rhythm Pharmaceuticals (RYTM) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

RZLT PE Ratio History
SAGE PE Ratio History
SANA PE Ratio History
SAVA PE Ratio History
SBTX PE Ratio History
SCPH PE Ratio History
SCPS PE Ratio History
SCTL PE Ratio History
SCYX PE Ratio History
SDC PE Ratio History
How should the RYTM historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Rhythm Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this RYTM Historical PE Ratio page.

What is the average historical PE for RYTM based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The RYTM historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for RYTM based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The RYTM historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the RYTM Historical PE Ratio information for Rhythm Pharmaceuticals' stock. The average RYTM historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average RYTM historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this RYTM historical PE result, against the recent PE: when this page was posted on 8/3/2022, the most recent closing price for RYTM had been 17.53, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on RYTM or any other given stock, valuation analysis for RYTM can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Rhythm Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RYTM. Thanks for visiting, and the next time you need to research RYTM Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of BITS, INGN Price Target, OTT Insider Buying.

 

RYTM Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.